These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 17487253
21. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Markoulaki D, Kostikas K, Papatheodorou G, Koutsokera A, Alchanatis M, Bakakos P, Gourgoulianis KI, Roussos C, Koulouris NG, Loukides S. Eur J Intern Med; 2011 Feb; 22(1):103-7. PubMed ID: 21238904 [Abstract] [Full Text] [Related]
27. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease. Piehl-Aulin K, Jones I, Lindvall B, Magnuson A, Abdel-Halim SM. Respiration; 2009 Dec; 78(2):191-6. PubMed ID: 19270439 [Abstract] [Full Text] [Related]
30. Are systemic inflammatory profiles different in patients with COPD and metabolic syndrome as compared to those with COPD alone? Stanciu S, Marinescu R, Iordache M, Dumitrescu S, Mureşan M, Bogdan MA. Rom J Intern Med; 2009 Dec; 47(4):381-6. PubMed ID: 21179920 [Abstract] [Full Text] [Related]
31. Variations in population-based levels of C-reactive protein, cardiovascular morbidity and all-cause mortality: an analysis of the relationship between C-reactive protein, Troponin-T, cardiovascular morbidity and death rates in an unselected population in Southwest Norway. Munk PS, Melberg TH, Skadberg O, Kvaløy JT, Larsen AI. Int J Cardiol; 2010 Apr 15; 140(2):247-9. PubMed ID: 19108919 [Abstract] [Full Text] [Related]
36. Exercise-induced systemic effects in muscle-wasted patients with COPD. Van Helvoort HA, Heijdra YF, Thijs HM, Viña J, Wanten GJ, Dekhuijzen PN. Med Sci Sports Exerc; 2006 Sep 15; 38(9):1543-52. PubMed ID: 16960513 [Abstract] [Full Text] [Related]
37. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P. Am J Kidney Dis; 2009 Jun 15; 53(6):1024-33. PubMed ID: 19394732 [Abstract] [Full Text] [Related]
38. [Statins in COPD--theoretical reflections]. Hannink JD, Heijdra YF. Ned Tijdschr Geneeskd; 2010 Jun 15; 154():A2196. PubMed ID: 20977805 [Abstract] [Full Text] [Related]
39. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Meisinger C, Koenig W, Baumert J, Döring A. Arterioscler Thromb Vasc Biol; 2008 Jun 15; 28(6):1186-92. PubMed ID: 18356554 [Abstract] [Full Text] [Related]